Scholars Central

Conference abstractPublished 5 Jul 2018

Untitled abstract

Authors: Surendra Lalwani

Formulation and evaluation of extended release drug delivery system of metformin hydrochloride

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Extended release pharmaceutical products became a very useful tool in medical practice, offering a wide range of actual and perceived advantages to the patient. Oral extended release drug delivery system becomes a promising approach for those drugs that are given orally, having the shorter half- life and high dosing frequency. Extended release provides promising way to decrease the side effect of the drug by preventing the fluctuation of the therapeutic concentration of the drug in the body. Recent trends indicate that multi particulate drug delivery systems are especially suitable for achieving extended release oral formulations with low risk of drug dumping, flexibility of blending to attain different release patterns as well as reproducible and short gastric residence time. The release of drug from pellets depends on the variety of factors including the carrier used to form pellets and the amount of drug contained in them. Consequently, pellets provide tremendous opportunities for designing new controlled and extended release oral formulations, thus extending the frontier of future pharmaceutical development. In the present study extended release tablets of Metformin hydrochloride (an oral antihyperglycemic drug) were formulated by using polymers of different viscosity grade such as HPMC K4M, HPMC K15M, HPMC K100M by wet granulation method. The formulated granules blends were evaluated for compatibility, angle of repose, true density, bulk density, compressibility index. The formulated tablets were subjected to thickness, weight variation test, hardness test, friability test and drug content. In vitro dissolution studies carried out in 6.8 phosphate buffer using the apparatus Type 2 paddle type as described in the USP dissolution monograph. The best extended performance and the best in vitro drug release profile were achieved by formulation F5 which contains drug; HPMC K4M in a ratio of 1:6. The tablets were released the drug up to 12hr and had maximum extended lag time. There was no significant change in physical and chemical properties of the tablets of formulation F5 after 3 Months, parameters like % drug release and assay values at various conditions as per ICH guidelines.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • BylineArticles whose byline prints “Surendra Lalwani”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels